Dr Andrea Jensen Matich, MD | |
96 E Kimballs Ln Ste 207, Draper, UT 84020-5021 | |
(801) 576-2300 | |
(844) 249-1746 |
Full Name | Dr Andrea Jensen Matich |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 19 Years |
Location | 96 E Kimballs Ln Ste 207, Draper, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902092133 | NPI | - | NPPES |
1265638357 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QS0010X | Family Medicine - Sports Medicine | 6354383-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lone Peak Hospital | Draper, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mountainstar Specialty Services Llc | 4688767551 | 30 |
News Archive
Surgical site infections are noteworthy and costly health complications. Patients with infections are likely to stay longer an intensive care unit and a hospital.
The team of South Korean scientists who cloned the first human embryo to use for research have now have used the same technology to create batches of embryonic stem cells from nine patients.
Personal choices, such as smoking and consumption of fatty foods, have long been linked to increased cancer risk. During recent years, scientists have been seeking to isolate a variety of lifestyle decisions that may stave off the onset of cancer or even reduce tumor formation in their early stages.
A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.
› Verified 9 days ago
Entity Name | Mountainstar Specialty Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265638357 PECOS PAC ID: 4688767551 Enrollment ID: O20070908000097 |
News Archive
Surgical site infections are noteworthy and costly health complications. Patients with infections are likely to stay longer an intensive care unit and a hospital.
The team of South Korean scientists who cloned the first human embryo to use for research have now have used the same technology to create batches of embryonic stem cells from nine patients.
Personal choices, such as smoking and consumption of fatty foods, have long been linked to increased cancer risk. During recent years, scientists have been seeking to isolate a variety of lifestyle decisions that may stave off the onset of cancer or even reduce tumor formation in their early stages.
A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrea Jensen Matich, MD Po Box 100253, Atlanta, GA 30384-0253 Ph: (801) 568-5972 | Dr Andrea Jensen Matich, MD 96 E Kimballs Ln Ste 207, Draper, UT 84020-5021 Ph: (801) 576-2300 |
News Archive
Surgical site infections are noteworthy and costly health complications. Patients with infections are likely to stay longer an intensive care unit and a hospital.
The team of South Korean scientists who cloned the first human embryo to use for research have now have used the same technology to create batches of embryonic stem cells from nine patients.
Personal choices, such as smoking and consumption of fatty foods, have long been linked to increased cancer risk. During recent years, scientists have been seeking to isolate a variety of lifestyle decisions that may stave off the onset of cancer or even reduce tumor formation in their early stages.
A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.
› Verified 9 days ago
Dr. Gordon Thier Oremland, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12422 S 450 E, Draper, UT 84020 Phone: 801-748-1600 Fax: 801-748-1601 | |
Geoffrey Thomas Osmond, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 11760 S 700 E Ste 112, Draper, UT 84020 Phone: 801-572-1186 | |
Jessica Wilkinson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13953 S Bangerter Pkwy, Draper, UT 84020 Phone: 385-900-4090 Fax: 801-365-1033 | |
Daniel Trevor Young, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 74 E Kimballs Ln Ste 300, Draper, UT 84020 Phone: 801-572-0311 | |
Harold N Gooch, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12176 South 1000 East, Draper, UT 84020 Phone: 801-572-3750 Fax: 801-572-1097 | |
Bradley Prestwich, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12473 S Minuteman Dr, Draper, UT 84020 Phone: 801-495-7910 Fax: 801-495-7990 | |
Dr. Layne A Hermansen, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 877 E 12300 S, Suite 201, Draper, UT 84020 Phone: 801-542-7111 Fax: 801-542-7112 |